Profile for Canada Patent: 2626956
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2626956
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Apr 28, 2026 | Viiv Hlthcare | APRETUDE | cabotegravir |
⤷ Sign Up | Apr 28, 2026 | Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine |
⤷ Sign Up | Apr 28, 2026 | Viiv Hlthcare | VOCABRIA | cabotegravir sodium |
⤷ Sign Up | Apr 28, 2026 | Viiv Hlthcare | APRETUDE | cabotegravir |
⤷ Sign Up | Apr 28, 2026 | Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |